Unique features of MOG-AD are the high frequency of ON attacks, good long-term neurological recovery, and sensitivity to steroid therapy.[7] There is a clear distinction in the clinical characteristics (including main symptoms, MRI findings, and response to steroid treatment) between MOG-AD and anti-NMDARe. This evidence concerns the gene MOG and Alzheimer disease.